Latest / Journey Through the Growth Economy
Checking in on the Diagnostics sector with CG Senior Analyst Kyle Mikson, CFA
Join us for this lively discussion with CG Managing Director and Senior Analyst Kyle Mikson, CFA, as we explore the evolving life science research tools and healthcare diagnostics landscape, including a fresh look at the bioprocessing sector, and how Trump appointees may impact funding for the NIH.
Kyle Mikson, CFA, is a Managing Director and Senior Analyst covering the Medical Tools and Diagnostics sector here at CG. Kyle earned a BS in Biomedical Engineering from Case Western Reserve University and worked in a variety of industry and investment-related roles before joining CG in 2021. In…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.